Director, Medical Affairs Strategy

Boehringer Ingelheim

Ridgefield (CT)

Sur place

USD 250 000 - 394 000

Plein temps

14 jours+

Une candidature complète en une minute

Un CV et une lettre de motivation personnalisés, prêts à envoyer.

Passez les filtres ATS

Résumé du poste

Boehringer Ingelheim is seeking a Director, Medical Affairs Strategy Team Member in the US to shape the medical strategic framework for bronchiectasis products. You will coordinate with corporate partners, US Launch Teams, and cross-functional groups to align medical launch readiness with corporate goals.

You will translate TA priorities into integrated medical plans, manage budgets, and drive evidence generation, with emphasis on collaboration across Medical Excellence, RWE, and Market Access

Qualifications

  • Ten (10) years of professional experience in a scientific, clinical, and/or medical space, including seven (7) years in a relevant pharmaceutical or related industry role.
  • Three-plus (3+) years’ experience in Medical Affairs supporting relevant Therapeutic area.
  • Experience in medical/scientific dialogue with Health Systems and Payers strongly preferred.
  • Demonstrated experience with pharmaceutical drug development and use of data analysis for strategy development, business process improvement, product launch planning, and integrated evidence generation.
  • Ability to collaborate, influence, and lead with executive presence, establishing strategic direction and driving execution.
  • Ability to translate scientific and medical market insights into medical tactical plans for effective launches of pharmaceutical products in the US.
  • Ability to travel with some overnights away from home as required by the role.

Responsabilités

  • Drives US collaboration with Corporate TAs to create a consolidated medical strategy and integrated evidence plan for bronchiectasis products/indications.
  • Leads indication- or product-specific co-creation with corporate partners of Global Integrated Business Plans (IBPs) to ensure US needs are integrated.
  • Leads creation of US Medical Affairs Plans (MAPs) and implements Launch Excellence tactics in Medical Affairs.
  • Drives execution of medical tactics and data release activities; stays abreast of paradigm shifts in clinical practice.
  • Promotes synergies across the product lifecycle with US TAs, Corporate medical, US franchise, and CDMA leaders.
  • Partners with the Medical Affairs Strategy Executive Director to integrate prioritized US clinical practice dynamics into programs.
  • Leads integration of insights, planning, execution, and analysis of evidence programs and content resources.
  • Ensures strategic congress planning, medical education, advisory boards, and publications alignment.

Formation

Bachelor’s degree required or higher
Advanced degree (PharmD, NP, PA, Master’s, MD, DO, PhD)
MBA with BSc./BSN combination
Other medically qualified licensure (e.g., RPh, Respiratory Therapist)

Description du poste

Boehringer Ingelheim is seeking a Director, Medical Affairs Strategy Team Member in the US to shape the medical strategic framework for bronchiectasis products. You will coordinate with corporate partners, US Launch Teams, and cross-functional groups to align medical launch readiness with corporate goals.

You will translate TA priorities into integrated medical plans, manage budgets, and drive evidence generation, with emphasis on collaboration across Medical Excellence, RWE, and Market Access

Obtenez votre examen gratuit et confidentiel de votre CV.

ou faites glisser et déposez votre fichier ici.

Similar jobs

Postes similaires à comparer

Director, Medical Affairs Strategy – Respiratory (Hybrid)
Director, Medical Affairs Strategy – Respiratory (Hybrid)

Boehringer Ingelheim GmbH • Ridgefield (CT)

Hybride
USD 250 000 - 394 000
Director, Medical Affairs Strategy Team Member - Respiratory (Hybrid)
Director, Medical Affairs Strategy Team Member - Respiratory (Hybrid)

Boehringer Ingelheim GmbH • Ridgefield (CT)

Sur place
USD 250 000 - 394 000
Head of US Bronchiectasis Brand & Launch Strategy
Head of US Bronchiectasis Brand & Launch Strategy

Boehringer Ingelheim Pharmaceuticals, Inc. • Ridgefield (CT)

Hybride
USD 288 000 - 432 000
Health insurance
US Brand Lead, Bronchiectasis: Launch & Growth
US Brand Lead, Bronchiectasis: Launch & Growth

Boehringer Ingelheim • Ridgefield (CT)

Hybride
USD 288 000 - 432 000
Relocation assistance
Discretionary bonus eligibility
Comprehensive benefits (medical,Dental
+3
VP, US Brand Lead for Bronchiectasis Launch
VP, US Brand Lead for Bronchiectasis Launch

Boehringer Ingelheim GmbH • Ridgefield (CT)

Sur place
USD 288 000 - 432 000
Medical
Dental
Vision coverage
+5
Director, Medical Affairs Strategy Team Member - Respiratory (Hybrid)
Director, Medical Affairs Strategy Team Member - Respiratory (Hybrid)

Boehringer Ingelheim • Ridgefield (CT)

Sur place
USD 250 000 - 394 000
Senior Marketing Executive, US Brand Strategy
Senior Marketing Executive, US Brand Strategy

Boehringer Ingelheim Pharmaceuticals, Inc. • Ridgefield (CT)

Sur place
USD 262 000 - 394 000
Relocation assistance
Senior Medical Evidence & Implementation Strategist
Senior Medical Evidence & Implementation Strategist

Boehringer Ingelheim Pharmaceuticals, Inc. • Ridgefield (CT)

Sur place
USD 191 000 - 294 000
Director, US Medicine Strategy & Transformation
Director, US Medicine Strategy & Transformation

Boehringer Ingelheim GmbH • Ridgefield (CT)

Sur place
USD 223 000 - 335 000
Director, Clinical Evidence Implementation - Respiratory
Director, Clinical Evidence Implementation - Respiratory

Boehringer Ingelheim • Ridgefield (CT)

Sur place
USD 180 000 - 280 000